68
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Response to Combined Antiretroviral Therapy According to Gender and Origin in a Cohort of Naïve HIV-Infected Patients: GESIDA-5808 Study

, , , , , , , , , , , & show all
Pages 131-141 | Published online: 06 Jan 2015

REFERENCES

  • Jarrin I, Geskus R, Bhaskaran K, et al. Gender differences in HIV progression to AIDS and death in industrialized countries: slower disease progression following HIV seroconversion in women. Am J Epidemiol. 2008; 168(5):532–540.
  • Garcia de la Hera M, Ferreros I, del Amo J, et al. Gen-der differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting drug users from 1986 to 2001. J Epidemiol Community Health. 2004;58(11):944–950.
  • Collazos J, Asensi V, Carton JA. Sex differences in the clinical, immunological and virological param-eters of HIV-infected patients treated with HAART. AIDS. 2007;21(7):835–843.
  • Finkel DG, John G, Holland B, Slim J, Smith SM. Women have a greater immunological response to effective viro-logical HIV-1 therapy. AIDS. 2003;17(13):2009–2011.
  • Nicastri E, Angeletti C, Palmisano L, et al. Gender differ-ences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy. AIDS. 2005;19(6):577–583.
  • Nicastri E, Leone S, Angeletti C, et al. Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review. J Antimicrob Chemother. 2007;60(4):724–732.
  • Prins M, Meyer L, Hessol NA. Sex and the course of HIV infection in the pre- and highly active antiretroviral therapy eras. AIDS. 2005;19(4):357–370.
  • Floridia M, Giuliano M, Palmisano L, Vella S. Gender dif-ferences in the treatment of HIV infection. Pharmacol Res. 2008;58(3–41) 73–182.
  • Iliovich E, Lopez R, Kum M, Uzandizaga G. [Spontaneous chagasic peritonitis in a patient with AIDS]. Medicina (B Aires). 1998;58(5 Pt 1):507–508.
  • Lanoy E, Mary-Krause M, Tattevin P, et al. Frequency, determinants and consequences of delayed access to care for HIV infection in France. Antivir Ther 2007;12(1):89–96.
  • Van Lunzen J, Fatkenheuer G, Lutz T, et al. Late presenta-tion is frequent in the elderly, in females and in patients from high prevalence countries in a German outpatient cohort. Presented at: 5th Conference on HIV Pathogenesis, Treat-ment and Prevention; July 2009; Cape Town. MOPEB061.
  • Burns FM, Imrie JY, Nazroo J, Johnson AM, Fenton KA. Why the(y) wait? Key informant understandings of factors contributing to late presentation and poor utilization of HIV health and social care services by African migrants in Britain. AIDS Care. 2007;19(1):102–108.
  • Del Amo J, Likatavicius G, Perez-Cachafeiro S, et al. The epidemiology of HIV and AIDS reports in migrants in the 27 European Union countries, Norway and Iceland: 1999-2006. Eur J Public Health. 2011 ;21(5):620–626.
  • Navaza B, Guionnet A, Navarro M, Estevez L, Perez-Molina JA, Lopez-Velez R. Reluctance to do blood test-ing limits HIV diagnosis and appropriate health care of Sub-Saharan African migrants living in Spain. AIDS Behav. 2011;16(1):30–35.
  • Situaci6n epidemiológica del VIH/Sida en Inmigrantes. Plan Nacional sobre el Sida/Ministerio de Sanidad y Politica Social y CNE/ISCIII/Ministerio de Ciencia e Inno-vación. 2009. www.isciii.es/htdocs/pdf/inmigrantes.pdf. Accessed October 12,2011.
  • Caro-Murillo AM, Castilla Catalan J, del Amo Valero J. [Epidemiology of HIV infection in immigrants in Spain: information sources, characteristics, magnitude and ten-dencies]. Gac Sanit. 2010;24(1):81–88.
  • Perez Molina JA, Rillo MM, Suarez-Lozano I, et al. Do HIV-infected immigrants initiating HAART have poorer treatment-related outcomes than autochthonous patients in Spain ? Results of the GESIDA 5808 Study. Curr HIV Res. 2011;8(7):521–530.
  • Perez-Hoyos S, Rodriguez-Arenas MA, Garcia de la Hera M, et al. Progression to AIDS and death and response to HAART in men and women from a multicenter hospital-based cohort. J Womens Health (Larchmt). 2007;16(7)1 052–1061.
  • Hawkins C, Chalamilla G, Okuma J, et al. Sex differ-ences in antiretroviral treatment outcomes among HIV-infected adults in an urban Tanzanian setting. AIDS. 2011;25(9):1189–1197.
  • Squires KE, Johnson M, Yang R, et al. Comparative gender analysis of the efficacy and safety of atazanavir/ ritonavir and lopinavir/ritonavir at 96 weeks in the CASTLE study. J Antimicrob Chemother 2011;66(2):363–370.
  • Currier J, Averitt Bridge D, Hagins D, et al. Sex-based out-comes of darunavir-ritonavir therapy: a single-group trial. Ann Intern Med. 2010 ;153(6):349–357.
  • Kempf MC, Pisu M, Dumcheva A, Westfall AO, Kilby JM, Saag MS. Gender differences in discontinuation of antiret-roviral treatment regimens. J Acquir Immune Defic Syndr 2009;52(3):336–341.
  • Tedaldi EM, Absalon J, Thomas AJ, Shlay JC, van den Berg-Wolf M. Ethnicity, race, and gender. Differences in serious adverse events among participants in an antiretroviral initiation trial: results of CPCRA 058 (FIRST Study). J Acquir Immune Defic Syndr 2008;47(4):441–448.
  • Roberts KJ, Mann T. Barriers to antiretroviral medica-tion adherence in HIV-infected women. AIDS Care. 2000;12(4):377–386.
  • Santos CP, Felipe YX, Braga PE, Ramos D, Lima RO, Segurado AC. Self-perception of body changes in per-sons living with HIV/AIDS: prevalence and associated factors. AIDS. 2005;19\(suppl 4):514–21.
  • Ripamonti D, Cattaneo D, Maggiolo F, et al. Atazanavir plus low-dose ritonavir in pregnancy: pharmacokinetics and placental transfer. AIDS. 2007;21(18):2409–2415.
  • Stek AM, Mirochnick M, Capparelli E, et al. Reduced lopinavir exposure during pregnancy. AIDS. 2006;20(15): 1931–1939.
  • von Hentig N, Carlebach A, Gute P, et al. A comparison of the steady-state pharmacokinetics of nevirapine in men, nonpregnant women and women in late pregnancy. Br J Clin PharmacoL 2006;62(5):552–559.
  • Staehelin C, Keiser O, CaImy A, et al. Longer term clinical and virological outcome of Sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort Study. J Acquir Immune Defic Syndr. 2012;59(1):79–85.
  • Gutierrez M, Tajada P, Alvarez A, et al. Prevalence of HIV-1 non-B subtypes, syphilis, HTLV, and hepatitis B and C viruses among immigrant sex workers in Madrid, Spain. J Med ViroL 2004;74(4):521–527.
  • Belza MJ, Clavo P, Ballesteros J, et al. [Social and work conditions, risk behavior and prevalence of sexually trans-mitted diseases among female immigrant prostitutes in Madrid (Spain)]. Gac San/t. 2004;18(3):177–183.
  • Kalichman SC, Catz S, Ramachandran B. Barriers to HIV/ AIDS treatment and treatment adherence among African-American adults with disadvantaged education. J Nati Med Assoc. 1999;91(8):439–446.
  • Drummond PD, Mizan A, Wright B. HIV/AIDS knowledge and attitudes among West African immigrant women in Western Australia. Sex Health. 2008;5(3):251–259.
  • Hjelm K, Berntorp K, Apelqvist J. Beliefs about health and illness in Swedish and African-born women with gesta-tional diabetes living in Sweden. J Clin Nurs. 2011. doi: 10.1111/j.1365-2702.2011.03834.x.
  • Ndirangu EW, Evans C. Experiences of African immigrant women living with HIV in the U.K.: implications for health professionals. J Immigr Minor Health. 2009;11(2):108–114.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.